ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with CirrhosisFred Poordad, Barry Bernstein, Mitchell L. Shiffman et al.|New England Journal of Medicine|2014Cited by 877
Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trialsGregory J. Dore, Thomas Podsadecki, Florin Alexandru Căruntu et al.|Journal of Hepatology|2015Cited by 68